Page last updated: 2024-08-16

rizatriptan and 3-(2-carboxyindol-3-yl)propionic acid

rizatriptan has been researched along with 3-(2-carboxyindol-3-yl)propionic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdelrahman, A; Akkari, R; Alshaibani, S; Baqi, Y; Ghasimi, S; Kaufmann, O; Köse, M; Kostenis, E; Müller, CE; Namasivayam, V; Pillaiyar, T; Rafehi, M; Ritter, K; Simon, K; Spinrath, A; Zhao, Q1

Other Studies

1 other study(ies) available for rizatriptan and 3-(2-carboxyindol-3-yl)propionic acid

ArticleYear
3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17.
    Journal of medicinal chemistry, 2018, 09-27, Volume: 61, Issue:18

    Topics: Animals; Antineoplastic Agents; Astrocytoma; Calcium; Humans; Indoles; Models, Molecular; Molecular Structure; Protein Conformation; Rats; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Tumor Cells, Cultured

2018